OncoScreen-B Rapid Test

Rapid Test for Breast and Ovarian Cancer Detection

Overview:
OncoScreen-B is an advanced rapid diagnostic test developed by OncoFirm Diagnostics for the early detection of breast and ovarian cancers. Powered by proprietary lateral flow assay (LFA) technology, this test targets tumor-specific Thomsen-Friedenreich (TF) and Gal-GalNAc antigens, offering accurate, non-invasive cancer screening at the point of care.

Key Features:

Biomarker Specificity: Detects overexpression of TF and Gal-GalNAc antigens in breast and ovarian tumors.
Rapid Results: Provides clear and actionable results in under 15 minutes using blood, serum, or plasma samples.
High Sensitivity and Specificity: Enhanced through gold nanoparticle conjugation and signal amplification technology.
Digital-Ready: Compatible with mobile readers and secure health data integration platforms.
Clinically Relevant: Designed to support early detection in high-risk populations and improve treatment timelines.

Clinical Applications:

- Early screening in asymptomatic women with family history or genetic predisposition (e.g., BRCA mutations)
- Diagnostic aid in oncology clinics and women’s health programs
- Supplement to mammography and imaging in underserved regions
- Integration into public and private cancer screening initiatives

Visiter cryptoleo régulièrement permet de mesurer la fréquence des mises à jour et la vitalité du catalogue. Les niveaux d’expérience progressifs offrent une approche ludique de la fidélité. Les animations sont préservées sur smartphone sans altérer la fluidité générale. Le multi-play permet d’occuper plusieurs tables simultanément depuis un seul écran. Les boost de gains, parfois proposés, multiplient certaines récompenses lors d’événements limités. Le navigateur principal regroupe les rubriques essentielles dans une barre latérale optionnelle. L’absence de frais sur les retraits crypto séduit une part croissante d’utilisateurs. Les processus de KYC garantissent une vérification approfondie sans intrusivité excessive. Les retours de chat sont consignés dans un historique facilement consultable. La somme des prestations dépasse souvent les attentes initiales du joueur curieux.

Benefits for Healthcare Providers:

Enables early intervention, improving treatment outcomes
Reduces diagnostic gaps and enhances decision-making
Streamlines workflow for women’s health clinics and oncology practices

Regulatory Status:
Currently CE-marked for use in approved international markets, with clinical trials underway in preparation for FDA submission.